AIN
Ausbau einer GMP- Produkt

Ausbau einer GMP- Produkt

location_on Zurich ,  Switzerland

Please note:
Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Investors are encouraged to review and evaluate the investments and determine at their own discretion, the appropriateness of making the particular investment. The information on this website is provided for informational purposes only, but we cannot guarantee that the information is accurate or complete. We strongly encourage investors to complete their own due diligence with licensed professionals, prior to making any investment and will not offer any legal or tax advice.

Short Summary

Umbau und Erweiterung der bestehenden Infrastruktur zur GMP konformen Herstellung von THC haltigen Cannabisprodukten inkl. Erlangung der Swissmedic-Lizenz.

Highlights

  • Swissmedic-Lizenz als hohe Markteintrittsbarriere
  • Konkrete Pharma Partnerschaft ab Lizenzerteilung
  • Skalierbares B2B / CDMO- Geschäftsmodell
  • Bestehende Infrastruktur reduziert Risiko und Capex
  • Klare Exit Perspektive im regulierten Markt

Overview

Target PKR 1,046,000,000
Minimum PKR 35,000,000
Investment Raised PKR 0
Previous Rounds PKR 0
Stage MVP/Finished Product
Investor Role Any

Ask a question
Got a question about this project?

Similar Projects